Mycoplasma Pneumoniae

• USES: • For the temporary relief of symptoms including: • head pain • muscle pain • joint pain • nausea These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.ICD-10: R11.2

DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.

Recent PubMed references pinned to Mycoplasma Pneumoniae as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Development and rapid identification of a self-constructed MALDI-TOF MS library for Mycoplasma pneumoniae clinical isolates.
  Journal of infection in developing countries · 2026 · Cen K, Qin C, Wang J, et al.
  PMID 42263003DOI 10.3855/jidc.21859
• Comparative progress on the mechanisms of airway mucosal injury induced by different pathogens: SARS-CoV-2, influenza A virus, and Mycoplasma pneumoniae.
  Frontiers in cellular and infection microbiology · 2026 · Jia Y, Wang Y
  PMID 42211665DOI 10.3389/fcimb.2026.1777403
• Efficacy and safety of Doxycycline versus Macrolides for Mycoplasma pneumoniae INfectiOn in Children (DOMINO): a protocol for a multicentre, randomised, open-label, superiority trial.
  BMJ open · 2026 · Choi YY, Kang C, Choe YJ, et al.
  PMID 42191206DOI 10.1136/bmjopen-2026-117862
• Beyond the Lungs: Rising Pediatric Mycoplasma pneumoniae Infections with Extrapulmonary Manifestations in the Post-COVID-19 Pandemic Era.
  Journal of tropical pediatrics · 2026 · Kuruc AI, Aykac K, Cengiz AB, et al.
  PMID 42173085DOI 10.1093/tropej/fmag036
• Unveiling metagenomic and metabolomic signatures in mild and severe pneumonia caused by Mycoplasma pneumoniae in children.
  Microbial genomics · 2026 · Yang Y, Lian S, Li X, et al.
  PMID 42159601DOI 10.1099/mgen.0.001717
• Clinical characteristics, risk factors, and pathogen spectrum of mixed infections in children with Mycoplasma pneumoniae pneumonia: a retrospective cohort study of 1,428 cases from a children's medical centre in East China.
  Microbiology spectrum · 2026 · Wang C, Hua S, Li Y, et al.
  PMID 42117705DOI 10.1128/spectrum.03884-25
• Macrolide resistance and risk factors for refractory Mycoplasma pneumoniae pneumonia in pediatric patients from Wuhu, China: A retrospective cohort study.
  Medicine · 2026 · Jiang T, Xiang X, Li H, et al.
  PMID 42116381DOI 10.1097/MD.0000000000048663
• Development of a predictive model based on clinical indicators for refractory Mycoplasma pneumoniae pneumonia in children: a case-control study.
  Frontiers in cellular and infection microbiology · 2026 · Yu F, Zhou Y, Luo Z, et al.
  PMID 42088019DOI 10.3389/fcimb.2026.1725669

The 10 most recently updated of 28 ClinicalTrials.gov registrations naming Mycoplasma Pneumoniae as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study
  Recruiting · Interventional · 376 enrolled · Christoph Berger
  NCT06325293updated 2026-05-05
• Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
  Active not recruiting · Interventional · 1,000 enrolled · University of Nebraska
  NCT05864118updated 2026-04-17
• Study of the Characteristics of Acute Mycoplasma Resuscitation: ECRAN-PLASMA Study
  Active not recruiting · Observational · 100 enrolled · Assistance Publique - Hôpitaux de Paris
  NCT07479355updated 2026-03-18
• Effect of Probiotics on Mycoplasma Pneumoniae Pneumonia
  Completed · Interventional · 60 enrolled · Wecare Probiotics Co., Ltd.
  NCT06348095updated 2026-03-03
• Integrated Study on Gut Microbiota, Immune Indicators, and Trace Elements in Children With Respiratory Tract Infections
  Not yet recruiting · Observational · 120 enrolled · Min-Tze LIONG
  NCT07378852updated 2026-02-04
• Development and Validation of an Early Prediction Model for Severe Mycoplasma Pneumoniae Pneumonia in Children
  Completed · Observational · 964 enrolled · Beijing Friendship Hospital
  NCT07333833updated 2026-01-12
• Doxycycline vs. Macrolide for MRMP (DOMINO)
  Not yet recruiting · Phase 4 · Interventional · 208 enrolled · Young June Choe
  NCT07306234updated 2025-12-29
• Comparative Autoantibody and Immunologic Cell Marker Study
  Enrolling by invitation · Observational · 2,500 enrolled · Emory University
  NCT02422875updated 2025-09-30
• Combined Diagnostic Approach for Refractory Mycoplasma Pneumonia in Children
  Completed · Interventional · 260 enrolled · Children's Hospital of Hebei Province
  NCT07064278updated 2025-07-14
• Emission Patterns of Respiratory Pathogens
  Withdrawn · Observational · 0 enrolled · Wake Forest University Health Sciences
  NCT03491020updated 2025-01-15

Frequently asked questions

What is Mycoplasma Pneumoniae used for?

According to FDA labeling, Mycoplasma Pneumoniae carries indications including: USES: • For the temporary relief of symptoms including: • head pain • muscle pain • joint pain • nausea These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.